knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 01:50:06 - browse：3946

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Wegovy improves function in certain heart failure patients

WSS

FDA advisory panel to debate high blood pressure devices

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Pharma’s losing bet in New Jersey

Abortion policy in the spotlight at Republican debate

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Listen: Vivek Ramaswamy's star turn & leaky drug data

knowledge

knowledge

hotspot

Psychedelics group wrestles with new pharma identity

Clinicians often fail to acknowledge the pain caused by long Covid

The high cost of giving birth even with insurance

Listen: Vivek Ramaswamy's star turn & leaky drug data

How one medical school became remarkably diverse

Former Pear Therapeutics executives start new VC firm

Supreme Court strikes down use of affirmative action

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

DeSantis wants to import drugs. Biden’s FDA blasted his plan

explore

Intellia plays down concerns on accidental germline transmission

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

CDC says it’s too soon to assess risk posed by Covid subvariant

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Unmasking the 'centricity' illusion in clinical trials

Bird flu makes raw milk dangerous to consume, mouse study finds

hotspot

hotspot

focus

entertainment